Astrocytoma
📧 Sign up to get email alerts when something new happens for Astrocytoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Investigational Imaging Technique During Brain Surgery [NA]
A clinical trial evaluating an investigational imaging technique during brain tumor surgery has been suspended. The study involves astrocyto…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Pediatric Long-Term Follow-up and Rollover Study [Phase 4]
Pediatric long-term follow-up and rollover study (Phase 4) sponsored by Novartis is active but not recruiting, tracking outcomes in children…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas [NA]
A completed trial evaluating temporally-modulated pulsed radiation therapy after prior EBRT in adults with recurrent IDH-mutant gliomas, inc…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma [Phase 1]
A Phase 1 trial evaluating the safety and tolerability of CVGBM in adults with newly diagnosed MGMT-unmethylated glioblastoma or astrocytoma…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma [Phase 1]
Phase 1 trial evaluating mycophenolate mofetil in combination with standard of care for glioblastoma; study status is ACTIVE_NOT_RECRUITING.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial [Phase 2]
This Phase IIc randomized feasibility pilot trial evaluated cognitive behavioral therapy for insomnia in patients with primary brain tumors …
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
The clinical trial investigating microRNA-10b expression in glioma patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation [Phase 2]
Phase 2 clinical trial evaluating proton radiotherapy for pediatric brain tumors requiring partial brain irradiation has completed enrollmen…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma
This completed clinical trial evaluated whole-brain tumor burden metrics along with inflammatory and molecular markers to predict postoperat…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: PARP Inhibition for Gliomas (PI-4G or π4g) [Phase 2]
Phase 2 trial of a PARP inhibitor for gliomas was terminated, with results posted in 2024, evaluating recurrent glioblastoma, recurrent astr…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Impact of IDH Mutation and Adjuvant Chemo(radio)therapy on Survival Outcome in Grade II/III Astrocytoma
A completed clinical trial update investigating the impact of IDH mutation status and adjuvant chemo(radiotherapy) on survival in Grade II/I…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas [Phase 1, Phase 2]
A Phase I/Phase II study evaluating mebendazole for pediatric gliomas has completed. It enrolled children with various glial tumors, includi…
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma [Phase 2]
Phase 2 trial evaluating a Protein Phosphatase 2A inhibitor in recurrent glioblastoma and related gliomas completed, with results posted in …
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma [Phase 2]
Phase 2 trial updating safety and efficacy of TVI-Brain-1 for recurrent grade IV glioma; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma [Phase 2]
A Phase 2 trial evaluating TVB-2640 in combination with bevacizumab in first relapse high-grade astrocytoma (astrocytoma). Status completed …
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors [Phase 2]
Phase 2 clinical trial update on stem cell transplant for high-risk CNS tumors including glioblastoma and astrocytoma; trial completed.
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma [Phase 3]
Phase 3 trial evaluating post-radiation adjuvant temozolomide chemotherapy for residue low-grade glioma; recruiting status suggests ongoing …
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Nivolumab With DC Vaccines for Recurrent Brain Tumors [Phase 1]
Phase 1 trial evaluating nivolumab in combination with dendritic cell vaccines for recurrent brain tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: First in Patient Study for PF-06840003 in Malignant Gliomas [Phase 1]
Phase 1 trial update for PF-06840003 in malignant gliomas has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma [Phase 3]
Phase 3 trial comparing hyperfractionated radiotherapy with BCNU to conventional radiotherapy with BCNU in supratentorial malignant glioma.
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab [Phase 2]
Phase 2 clinical trial updating safety and efficacy of TH-302 CNS penetration in recurrent high-grade astrocytoma after bevacizumab, complet…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma [Phase 1, Phase 2]
A Phase 1/2 study of intraventricular liposomal cytarabine (DepoCyt) for recurrent glioblastoma was terminated, and results have been posted…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy [Phase 1, Phase 2]
Clinical trial update for SU5416 (Semaxanib) in patients with recurrent astrocytoma or mixed glioma after radiation failure; the Phase 1/2 s…
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Perampanel in Seizure Patients With Primary Glial Brain Tumors [Phase 4]
Phase 4 study of perampanel for seizures in patients with primary glial brain tumors completed; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745) [Phase 2]
Phase II monotherapy trial of SCH 52365 for first-relapsed anaplastic astrocytoma has completed; the snippet does not provide efficacy or sa…